TELA Bio (TELA) Other Non-Current Liabilities (2018 - 2026)

TELA Bio has reported Other Non-Current Liabilities for 9 years, with the latest figure at $1.3 million in Q2 2026.

• On a quarterly basis, Other Non-Current Liabilities rose 5.16% year-over-year to $1.3 million in Q2 2026; TTM through Jun 2026 was $1.3 million, a 5.16% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 6.26% from the prior year.
• Other Non-Current Liabilities was $1.3 million for Q2 2026 at TELA Bio, down from $1.4 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $1.7 million in Q4 2023, with the low at $1.1 million in Q3 2023.
• Average Other Non-Current Liabilities over 5 years is $1.4 million, with a median of $1.3 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities jumped 16925.0% in 2022, then dropped 18.78% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $1.2 million in 2022, then surged by 36.88% to $1.7 million in 2023, then slipped by 17.51% to $1.4 million in 2024, then gained by 6.26% to $1.5 million in 2025, then fell by 11.65% to $1.3 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $1.3 million (Q2 2026), $1.4 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.